ABSTRACT aIM: The aim of this study was to determine the serum heart-type fatty acid binding protein (H-FABP) levels and cardiac effects in patients presenting with subarachnoid hemorrhage (SAH) and to investigate whether any correlation exists between the cardiac effects and H-FABP.
Is There a Relationship Between Serum HeartType Fatty Acid Binding Protein Level and Clinical Severity in Patients with Subarachnoid Hemorrhage?

Subaraknoid Kanamalı Hastaların Klinik Şiddeti ile Kalp Tipi Yağ Asidi Bağlayıcı Proteinin Serum Düzeyi Arasında İlişki Var mıdır?
InTRoduCTIon Spontaneous subarachnoid hemorrhage (SAH) is a serious problem encountered in emergency and neurosurgery practice (3). It is difficult to define a precise value regarding the incidence of SAH; the reported incidence has ranged from 8 to 25 per 100,000 (1, 8, 12, 20, 23, 28) . The initial severity of bleeding, cerebral vasospasm, repetitive bleeding, success of the surgical intervention, and postoperative complications are common factors that are effective on the morbidity and mortality of the cases (13). Data from the studies conducted show that the mortality rate varies, reaching a value of 50% in the first month after hemorrhage (26) . It is important to conduct a precise evaluation of the patient's clinical status in the management of treatment modalities and determination of the prognosis. Cerebrovascular spasm (CVS) has an important role in the mortality and morbidity of the cases, and should be considered among the factors that may affect the clinical status of SAH (2).
Heart-type fatty acid binding protein (H-FABP) is a small protein (15 kDa) in the cytoplasm of heart muscle cells. H-FABP has been shown also in the distal tubule of the kidney, skeletal muscle and brain cells, lactating mammary glands, and the placenta. H-FABP and brain-type fatty acid binding protein (B-FABP) are the new potential markers for detecting brain damage (22) .
mATeRIAl and meThodS
This prospective study was performed in Ondokuzmayıs University, School of Medicine, Emergency Department, from January 2011 to October 2011. Forty-six patients with spontaneous SAH were included in this study. In addition, 20 healthy adults were enrolled in the study to serve as a control group. A detailed physical examination was performed in all patients in the emergency room during the first application. Data from the patients included in the study were recorded during the first application. The imaging modalities [X-ray, computerized brain tomography (BT), electrocardiography (ECG), angiography], duration of hospitalization, and the last status of the patient (healing, exitus, vegetative state, and referral) were recorded. Verbal and written consent was obtained from patients and their relatives. Exclusion criteria were as follows: presentation more than 24 hours after hemorrhage, traumatic SAH, pregnant women with SAH, presence of kidney, liver or heart failure with SAH, and age less than 18 years. Venous blood samples were taken from patients diagnosed as SAH at presentation, and emergency biochemical investigations and complete blood count were done. In addition, to determine serum H-FABP levels, a 5 mL venous blood sample was taken at the same time. Blood samples were taken from a tube without anticoagulant and were centrifuged at 1500 g rpm for 15 minutes. The serum polypropylene tubes were stored at -70°C until the final analysis. The same procedures were performed for venous blood samples taken from patients in the control group. Serum H-FABP levels were measured with the test kit HyCult (HK401) by using the monoclonal antibodies and non-competitive sandwich-type enzyme-linked immunosorbent assay (ELISA) method from Biotechnology (Uden, Netherlands). Measurements were made using the Tecan Sunrise ELISA Reader device. Clinical classification of patients was made according to the Hunt and Hess scale for clinical classification of SAH. BT scan was used for evaluating patients according to the Fisher radiological scale (Table I, II).
Exitus and surviving patients were grouped according to prognosis. All data were recorded using the SPSS 15.0 (Statistical Package for the Social Sciences) computer program. Because the data do not fit a normal distribution, nonparametric tests were used. The Mann-Whitney U test was used for two-group comparisons.
For comparison of more than two groups, the Kruskal-Wallis analysis of variance followed by Bonferroni-corrected MannWhitney U test was used, and Spearman correlation analysis was performed (r=0.38) (p<0.05).
Continuous variables of the data evaluated were expressed as mean ± standard deviation. The data do not fit a normal distribution; thus, descriptive statistics are presented as the median (min-max).
ReSulTS
Of the 46 patients, 21 were males (45.7%) and 25 were females (53.3%). The mean age of the patients was 53.8 ± 16.2 years. The largest group of patients was between the ages of 46-55 years (n=13, 28.3%) (Table III) .
Seventy-eight percent of patients had several ECG changes. Most patients (91.3%) showed normal sinus rhythm, and atrial fibrillation was found in 8.7% of the patients. The mean ECG velocity was found as 84.1±21.4, while the median (min-max) Severe headache, neck stiffness, no neurological signs other than cranial nerve palsy grade 3
Drowsiness, confusion, and moderate neurological signs grade 4
Stupor, moderate-severe hemiparesis grade 5
Deep coma and decerebrate posture Figure 1 ).
The neurological status of patients was evaluated according to the Hunt and Hess scale at the time of the first application, and 19 of 46 patients (41.3%) were determined as Grade 1, followed in decreasing order of frequency by Grade 5, Grade 3-4, and Grade 2 (Figure 2 ).
There was a moderate positive correlation between H-FABP serum levels and the grade according to the Hunt and Hess classification (r=0.43, p<0.05) (Table V, Figure 3 ).
There was a weak positive correlation between H-FABP serum levels and the grade according to the Fisher radiological classification (r=0.38, p<0.05) (Table VI, Figure 4) .
We examined the relationship between serum H-FABP levels and prognosis, and found that H-FABP levels were significantly Figure 5 ).
The sensitivity and specificity of a serum H-FABP level ≥6 ng/dl indicating mortality were 83.3% and 42.9%, respectively. The positive predictive value was found as 48.4% and negative predictive value as 80%. (27) reported that their largest group (26.2%) was Grade 2. Bozkus and Sarioglu (4) reported that Grade 1 SAH was more likely seen under the age of 40 (66%), and with an increase in age, this ratio fell to 30%. In our study, the largest group was determined as Grade 1 (41.3%). In the various studies, patients with Grades 1-3 (low grade) were defined as having a good prognosis, while those with Grades 4-5 (high grade) were defined as having a poor prognosis (17) . Many neurosurgeons prefer not to operate on patients with poor prognosis because of the difficulty of the surgery, high mortality and morbidity, and low functional recovery (17) . In different studies, patients with low grade have demonstrated better clinical results than those with high grade (5,31). Koivisto et al. (15) reported that patients with Grades 4-5 have increased morbidity and mortality after surgical and endovascular treatment.
The Fisher grading scale is the most common method used to evaluate the SAH based on the computed tomography appearance (7). Although the Fisher scale was developed to estimate the CVS in patients with SAH, it is reported to be correlated with clinical outcomes (19) . Fisher et al. (7) also documented that an increase in the Fisher grade increases the rate of CVS. In one study, it was reported that the classification according to Hunt and Hess grade increases in direct proportion to increase in vasospasm (10). Goddard et al. (9) stated that the patient's neurological status at the time of arrival and the Fisher grade are effective on development of vasospasm. CVS has an important role in terms of mortality and morbidity, and is also considered to be among the factors that affect the clinical status of patients with SAH (2). To
